Genome sequencing reveals antimicrobial properties of Streptomyces sp. AM6-12, suggesting potential for drug discovery.
Streptomyces strain AM6-12 was isolated from Restinga de Marambaia soil and is able to completely inhibit the growth of Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa . Here we report on its genome sequence, with 7,958,853 bp and a 71.89% G+C content.
No takes yet. Share an insight, caveat, or question.
Oliveira et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: